Clinical Trial Update: Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics, pharmacodynamics, and safety update for MT-1303 in subjects with Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• MT-1303

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Crohn's Disease | Phase 1 | Status: COMPLETED